Kevin Bruce Johnson
Chief Regulatory Officer · Tourmaline Bio, Inc.
Individual
- 2025
- Oct 28, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Kevin Bruce Johnson's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Bruce Johnson?
Kevin Bruce Johnson is a corporate insider, tracked as Chief Regulatory Officer of Tourmaline Bio, Inc. (TRML). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kevin Bruce Johnson last file a Form 4?
The most recent primary Form 4 on record is dated 28 October 2025, one of 2 filings going back to 2025.
